FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age

On Friday, October 26, the U.S. Food and Drug Administration (FDA) amended Pfizer-BioNTech’s Emergency Use Authorization to allow the vaccine to be administered to children ages 5 to 11 years. FDA resources are available at:

• Press Release
• Updated Pfizer Factsheets
• Emergency Use Authorization for Vaccines Explained | FDA

Please note that the current Pfizer-BioNTech vaccine you have should NOT be used for administering to children ages 5 through 11 years. Pediatric Pfizer-BioNTech vaccine is being shipped to jurisdictions now and will arrive next week. On Tuesday, November 2, CDC’s Advisory Committee on Immunization Practices (ACIP) will meet to discuss a recommendation for the Pfizer-BioNTech COVID-19 Vaccine for children. View the meeting agenda here and watch the livestream. Until ACIP and CDC recommend the use of this vaccine in this age group, no children ages 5 through 11 years should be vaccinated.

We will share additional information following the ACIP meeting.